Literature DB >> 16094691

C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells.

Monika Pruenster1, Doris Wilflingseder, Zoltán Bánki, Christoph G Ammann, Brigitte Muellauer, Martina Meyer, Cornelia Speth, Manfred P Dierich, Heribert Stoiber.   

Abstract

HIV directly activates the complement cascade and is, therefore, opsonized with C3-cleavage products in vivo. This cloud of C3 fragments on the viral surface may impair the interaction of the HIV envelope glycoproteins gp120/gp41 with C-type lectins expressed on immature dendritic cells (iDC). Therefore, we determined the accessibility of gp120 after opsonization and compared the interaction of DC with non-opsonized or complement-opsonized HIV. The recognition of native gp120 was drastically impaired when the virus was covered by complement. Independent of opsonization, similar amounts of HIV bound to DC. The interaction of iDC and the infection of DC-PBL co-cultures with non-opsonized virus was significantly reduced by mannan and antibodies which inhibit the ICAM-1-CR3 interaction. The binding of opsonized virus to iDC was reduced by an anti-CR3-antibody, which interferes with the binding of C3 fragments, but was not affected by mannan. Complement enhanced the HIV infection of DC and DC-PBL co-cultures significantly. Mannan did not inhibit the complement-dependent enhancement of infection. Thus, non-opsonized and opsonized HIV interacted with iDC, although the binding mechanisms seemed to differ. As HIV is opsonized in vivo, the C-type lectin-independent interaction of opsonized viruses with iDC has to be taken into account.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16094691     DOI: 10.1002/eji.200425940

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  Impaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1.

Authors:  Rada Ellegård; Elisa Crisci; Jonas Andersson; Esaki M Shankar; Sofia Nyström; Jorma Hinkula; Marie Larsson
Journal:  J Immunol       Date:  2015-07-08       Impact factor: 5.422

Review 2.  The good and evil of complement activation in HIV-1 infection.

Authors:  Qigui Yu; Richard Yu; Xuebin Qin
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

Review 3.  Complement and HIV-I infection/HIV-associated neurocognitive disorders.

Authors:  Fengming Liu; Shen Dai; Jennifer Gordon; Xuebin Qin
Journal:  J Neurovirol       Date:  2014-03-18       Impact factor: 2.643

4.  Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3.

Authors:  Rada Ellegård; Elisa Crisci; Adam Burgener; Christopher Sjöwall; Kenzie Birse; Garrett Westmacott; Jorma Hinkula; Jeffrey D Lifson; Marie Larsson
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

5.  Generation of Human Monocyte-derived Dendritic Cells from Whole Blood.

Authors:  Wilfried Posch; Cornelia Lass-Flörl; Doris Wilflingseder
Journal:  J Vis Exp       Date:  2016-12-24       Impact factor: 1.355

6.  A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement.

Authors:  Leili Jia; Yuanyong Xu; Chuanfu Zhang; Yong Wang; Huihui Chong; Shaofu Qiu; Ligui Wang; Yanwei Zhong; Weijing Liu; Yansong Sun; Fei Qiao; Stephen Tomlinson; Hongbin Song; Yusen Zhou; Yuxian He
Journal:  Virol J       Date:  2010-06-29       Impact factor: 4.099

7.  Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.

Authors:  Zoltán Bánki; Wilfried Posch; Asim Ejaz; Verena Oberhauser; Suzanne Willey; Christoph Gassner; Heribert Stoiber; Ulf Dittmer; Manfred P Dierich; Kim J Hasenkrug; Doris Wilflingseder
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

8.  Complement receptor 3 promotes severe ross river virus-induced disease.

Authors:  Thomas E Morrison; Jason D Simmons; Mark T Heise
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

9.  Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors.

Authors:  Barbara Falkensammer; Barbara Rubner; Alexander Hiltgartner; Doris Wilflingseder; Christiane Stahl Hennig; Seraphin Kuate; Klaus Uberla; Stephen Norley; Alexander Strasak; Paul Racz; Heribert Stoiber
Journal:  Retrovirology       Date:  2009-06-21       Impact factor: 4.602

10.  Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways.

Authors:  Suraiya Rasheed; Jasper S Yan; Adil Hussain; Bruce Lai
Journal:  J Transl Med       Date:  2009-08-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.